Trini Pelaez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Trini Pelaez has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Anna Brunet
Unitat d'Antropologia Biològica, Departament de Biologia Animal, Biologia Vegetal i Ecologia, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Catalonia, Spain
1 shared publication - Elisabeth Gabau
Paediatric Unit, Parc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, 08208 Sabadell, Spain
1 shared publication - Lluís Armengol
Genes and Disease Program, Center for Genomic Regulation, Barcelona, Spain
1 shared publication - Miriam Guitart
Genetics Unit, Laboratory Service, Parc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, 08208 Sabadell, Spain
1 shared publication - Roser Guillamat
Department of Mental Health, Consorci Sanitari de Terrassa, Terrassa, Catalonia, Spain
1 shared publication - Vicenç Vallès
Behavioral Addictions Unit, Area of Mental Health Care, Consorci Sanitari de Terrassa, 08227 Terrassa, Spain
1 shared publication
Latest Publications
- Open Access
- 19 February 2008
- Published by Springer Nature in Behavioral and Brain Functions
- Vol. 4 (1) , 10
Failure to detect the 22q11.2 duplication syndrome rearrangement among patients with schizophrenia
Chromosome aberrations have long been studied in an effort to identify susceptibility genes for schizophrenia. Chromosome 22q11.2 microdeletion is associated with DiGeorge and Velocardiofacial syndromes (DG/VCF) and provides the most convincing evidence of an association between molecular cytogenetic abnormality and schizophrenia. In addition, this region is one of the best replicated linkage findings for schizophrenia. Recently, the reciprocal microduplication on 22q11.2 has been reported as a new syndrome. Preliminary data indicates that individuals with these duplications also suffer from neuropsychiatric disorders. In this study we have investigated the appropriateness of testing schizophrenia patients for the 22q11.2 microduplication. We used multiplex ligation-dependent probe amplification (MLPA) to measure copy number changes on the 22q11.2 region in a sample of 190 patients with schizophrenia. Our results corroborate the prevalence of the 22q11.2 microdeletion in patients with schizophrenia and clinical features of DG/VCFS and do not suggest an association between 22q11.2 microduplication and schizophrenia.
- 19 February 2008
- Published by Springer Nature in Behavioral and Brain Functions
- Vol. 4 (1) , 10
Open AccessFailure to detect the 22q11.2 duplication syndrome rearrangement among patients with schizophrenia
Chromosome aberrations have long been studied in an effort to identify susceptibility genes for schizophrenia. Chromosome 22q11.2 microdeletion is associated with DiGeorge and Velocardiofacial syndromes (DG/VCF) and provides the most convincing evidence of an association between molecular cytogenetic abnormality and schizophrenia. In addition, this region is one of the best replicated linkage findings for schizophrenia. Recently, the reciprocal microduplication on 22q11.2 has been reported as a new syndrome. Preliminary data indicates that individuals with these duplications also suffer from neuropsychiatric disorders. In this study we have investigated the appropriateness of testing schizophrenia patients for the 22q11.2 microduplication. We used multiplex ligation-dependent probe amplification (MLPA) to measure copy number changes on the 22q11.2 region in a sample of 190 patients with schizophrenia. Our results corroborate the prevalence of the 22q11.2 microdeletion in patients with schizophrenia and clinical features of DG/VCFS and do not suggest an association between 22q11.2 microduplication and schizophrenia.